Lorazepam
- Product NDC
- 68788-7355
- 11-digit product format
- 687887355
- Labeler code
- 68788
- Product ID
- 68788-7355_22b4a379-4ed5-41be-be19-8df8d6a9c4af
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lorazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA203572
- Marketing category
- ANDA
- Marketing start
- 2019-02-27
- Substance
- LORAZEPAM
- Active strength
- .5 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203572-001 | LORAZEPAM | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2017-12-22 | |
| A203572-002 | LORAZEPAM | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2017-12-22 | |
| A203572-003 | LORAZEPAM | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2017-12-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203572-001 | AB |
| A203572-002 | AB |
| A203572-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203572-001 | LORAZEPAM | 0.5MG | TABLET / ORAL | AB | 2017-12-22 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A203572-002 | LORAZEPAM | 1MG | TABLET / ORAL | AB | 2017-12-22 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A203572-003 | LORAZEPAM | 2MG | TABLET / ORAL | AB | 2017-12-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203572-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A203572-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A203572-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LORAZEPAM | LORAZEPAM | REMEDYREPACK INC. | 7fa1a011-5e28-4b13-bcd2-5c5fc9b663b2 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| LORAZEPAM | LORAZEPAM | Bryant Ranch Prepack | 46af8e93-3169-408a-b4d8-b8498642801d | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals Inc. | 4a50329b-b272-4164-bddf-0d6cea3d7a23 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 68788-7355 |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 11372b3d-52c0-4694-8c88-4b72d3fda9d0 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| LORAZEPAM | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0418ad09-3069-4381-9a8f-e41b234fdac6 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| LORAZEPAM | LORAZEPAM | Aurolife Pharma LLC | 5b851f67-309d-4ef3-8b4b-ade8908256ea | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | American Health Packaging | 45e31a87-a8db-4dda-b94b-83535b62e8e2 | 2025-09-14 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals, Inc. | 00960fbd-a5da-408b-9867-62982f20906f | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals, Inc. | 6cc1f35d-ff33-404e-aa5e-b01eab89863e | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8aaf9bcb-7a4e-ffaa-e053-2995a90a3913 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| LORAZEPAM | LORAZEPAM | DirectRx | ddcc0b2b-4be2-6d18-e053-2a95a90af987 | 2025-01-22 | Warnings, Adverse reactions | 203572 ANDA203572 |
| LORAZEPAM | LORAZEPAM | Advanced Rx of Tennessee, LLC | 2a57e549-390b-5482-e063-6394a90aeb3b | 2024-12-28 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8fa33078-c379-41f5-e053-2995a90acced | 2024-10-09 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 853c762d-0772-4f02-99ca-0bc2911f09f0 | 2024-08-26 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | a4fe8df0-3ce8-b8b8-e053-2995a90a28f4 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 8aace309-f3ef-6aef-e053-2995a90aa197 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| Lorazepam | LORAZEPAM | NuCare Pharmaceuticals,Inc. | 933b5ef3-ec29-1a96-e053-2995a90a2d33 | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| LORAZEPAM | LORAZEPAM | A-S Medication Solutions | 8602cef8-167e-4a8c-b10f-fc3295a3abcc | 2024-01-21 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| LORAZEPAM | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 247110f2-5468-4593-8d86-41f8c869e03d | 2023-10-17 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
| LORAZEPAM | LORAZEPAM | A-S Medication Solutions | 823b1d71-a510-4d34-8015-60b55af23d78 | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | 203572 ANDA203572 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lorazepam
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LORAZEPAM | .5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| O26FZP769L | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197900 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4a50329b-b272-4164-bddf-0d6cea3d7a23 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a759f740-8682-4896-9194-8b6c103c9aee | Product name | 3 | 20250716 |
| b7badb1c-6d3f-4f95-a4ca-ce69992e58a1 | Product name | 1 | 20220308 |
| 5d98a0ba-a64b-d9b2-e6ec-87edbb57a285 | Product name | 2 | 20180320 |
| ac8efea8-f412-295f-00ce-b095e5cbc115 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-7355-1 | Lorazepam | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 68788-7355-3 | Lorazepam | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 68788-7355-6 | Lorazepam | 60 in 1 BOTTLE | TABLET | 60 | 7 | |
| 68788-7355-8 | Lorazepam | 120 in 1 BOTTLE | TABLET | 120 | 7 | |
| 68788-7355-9 | Lorazepam | 90 in 1 BOTTLE | TABLET | 90 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-7355-1 | EA - Each | 68788-7355 | dcc49631-8e6f-44f9-a41e-7fe75957e2f7 | 1 | 2019-05-02 |
| 68788-7355-3 | EA - Each | 68788-7355 | c2a0b767-d43e-41f7-887a-150cf38c0eec | 1 | 2019-05-02 |
| 68788-7355-6 | EA - Each | 68788-7355 | e3000841-b7b0-418f-9b18-ff5e791e15d9 | 1 | 2019-05-02 |
| 68788-7355-8 | EA - Each | 68788-7355 | cc2eae51-38e7-4fb1-afbb-d5bee45002c0 | 1 | 2019-05-02 |
| 68788-7355-9 | EA - Each | 68788-7355 | c0b0f829-6304-4e62-aacc-1f17670361e7 | 1 | 2019-05-02 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-7355 | LORAZEPAM TABLET [PREFERRED PHARMACEUTICALS INC.] | 6 | Current NDC, Legacy NDC, 5 package rows | 20240628_4a50329b-b272-4164-bddf-0d6cea3d7a23.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197900 | LORazepam 0.5 MG Oral Tablet | PSN | 4a50329b-b272-4164-bddf-0d6cea3d7a23 | 8 |
| 197900 | lorazepam 0.5 MG Oral Tablet | SCD | 4a50329b-b272-4164-bddf-0d6cea3d7a23 | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68788-7355-1 | 68788735501 | 100 TABLET in 1 BOTTLE (68788-7355-1) | 100 tablet | 2019-02-27 | 0000-00-00 | No | No | Current |
| 68788-7355-3 | 68788735503 | 30 TABLET in 1 BOTTLE (68788-7355-3) | 30 tablet | 2019-02-27 | 0000-00-00 | No | No | Current |
| 68788-7355-6 | 68788735506 | 60 TABLET in 1 BOTTLE (68788-7355-6) | 60 tablet | 2019-02-27 | 0000-00-00 | No | No | Current |
| 68788-7355-8 | 68788735508 | 120 TABLET in 1 BOTTLE (68788-7355-8) | 120 tablet | 2019-02-27 | 0000-00-00 | No | No | Current |
| 68788-7355-9 | 68788735509 | 90 TABLET in 1 BOTTLE (68788-7355-9) | 90 tablet | 2019-02-27 | 0000-00-00 | No | No | Current |